Discover Hummsa’s pioneering oral GLP‑1 small‑molecule therapies targeting diabetes, obesity, fatty liver, osteoporosis & Alzheimer’s. Regeneration over symptom control.
Investors 2
| Date | Name | Website |
| 26.07.2024 | 100X.VC | 100x.vc |
| 10.07.2026 | Randev Ven... | randevvent... |
Mentions in press and media 1
| Date | Title | Description |
| - | Hummsa Biotech | “Hummsa’s InsGen kit uses DNA/RNA with nanoparticles to create DNA sensors that bind specifically and accurately with chosen targets to change colour and deliver results.” |